Get started
Author

Kevin McDermott

Observed names: Kevin T. McDermott, McDermott, Kevin
ORCID: 0000-0002-9415-8647
Observed ORCID: 0000-0002-9415-8647
OpenAlex ID: A5061481501
Duration of Protection After Vaccination Against Yellow Fever: A Systematic Review and Meta-Analysis
2022 · Kerstin Kling, Cristina Domingo, et al. · Clinical Infectious Diseases · 54
PDF
The quality of COVID-19 systematic reviews during the coronavirus 2019 pandemic: an exploratory comparison
2024 · Kevin T. McDermott, Mark Perry, et al. · Systematic Reviews · 13
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2023 · Giovany Orozco Leal, Nigel Armstrong, et al. · PharmacoEconomics · 8
PDF
Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2023 · Antoinette D. I. van Asselt, Nigel Armstrong, et al. · PharmacoEconomics · 5
PDF
Duration of protection after vaccination against yellow fever - systematic review and meta-analysis
2022 · Kerstin Kling, Cristina Domingo, et al. · medRxiv · 5
PDF
Surveillance of antibiotic-resistant bacteria integrating whole genome sequencing and epidemiological information – a global, systematic review, 2012–2023
2026 · Felix Reichert, Mark Perry, et al. · Antimicrobial Resistance and Infection Control
PDF
Additional file 3 of Surveillance of antibiotic-resistant bacteria integrating whole genome sequencing and epidemiological information – a global, systematic review, 2012–2023
2026 · Felix Reichert, Mark Perry, et al. · Figshare
Additional file 1 of Surveillance of antibiotic-resistant bacteria integrating whole genome sequencing and epidemiological information – a global, systematic review, 2012–2023
2026 · Felix Reichert, Mark Perry, et al. · Figshare
Additional file 2 of Surveillance of antibiotic-resistant bacteria integrating whole genome sequencing and epidemiological information – a global, systematic review, 2012–2023
2026 · Felix Reichert, Mark Perry, et al. · Figshare
Accounting for Genomic Testing Costs in Cost-Effectiveness Evaluations: Challenges and Lessons Learned from the NICE Single Technology Appraisal of Erdafitinib for Treating Unresectable or Metastatic Urothelial Cancer with FGFR3 Alterations After a PD-1 or PD-L1 Inhibitor
2026 · Andrea Fernández Coves, Mirre Scholte, et al. · PharmacoEconomics
PDF
Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
2026 · Mirre Scholte, Andrea Fernández Coves, et al. · PharmacoEconomics
PDF
Accuracy and clinical effectiveness of fetal growth monitoring strategies for the prediction of small for gestational age at birth: a systematic review and meta-analysis
2025 · Evangelos Danopoulos, Nigel Armstrong, et al. · Health Technology Assessment
Effectiveness and Cost-Effectiveness of Empathic Healthcare: A Systematic Review and Meta-analysis
2025 · Jeremy Howick, Claire Madigan, et al. · SSRN Electronic Journal
Works count: 14
Citation count: 85
H-index: 5
I10-index: 2
Year
Topic
Type